Fig. S1: Protein purification of all six Cascade subunits. (A) The soluble protein Csa5 was purified via a two-column strategy. Depicted are the pellet (P) and supernatant (S) fractions after cell lysis and ultracentrifugation, followed by the heat precipitated (HP, 90°C) Csa5 sample, further purified samples via Blue Sepharose affinity chromatography (BS) and MonoQ anion-exchange chromatography (MQ) on a 15% SDS gel next to the protein marker (M). (B) The insoluble subunits Cas5a, Cas3', Cas3'' and Cas8a2 were individually purified via inclusion body isolation and solubilization in 6 M GdmCl. The 15% SDS gel shows the subunits before usage in Cascade assembly. (C) The soluble subunit Cas7 was fused with a SUMO tag to omit cross-contamination with E. coli RNA and oligomerization. Depicted are the individual protein fractions alongside the protein marker (M) separated on a 15% SDS-PAGE. Cas7-SUMO was purified via Ni-NTA chromatography (NI), followed by a SUMO protease (S-P) treatment during dialysis. After concentration of native Cas7 (centrifugal filter units, MWCO: 30 kDa) the cleaved off SUMO tag was visible in the flow-through (FT). Cas7 was further purified with Heparin cation-exchange chromatography (HE) and gel filtration (GE) resulting in monomeric Cas7.
Cas3', e: Cas3'', f: Cas8a2), while the soluble proteins (a: Csa5, b: Cas7) are not taken into account. Only the combination that contained all six Cascade subunits (6p) showed a recovery of soluble protein above 50%, in contrast to combinations with missing subunits (1p-5p) that resulted in soluble protein of less than 10%.
Fig. S4
: Size-exclusion chromatograms of assembled Cascade. The Cascade subunits (Csa5, Cas7, Cas5a, Cas3', Cas3'' and Cas8a2) were assembled via the co-refolding procedure and incubated with synthetic crRNA 5.2 (crRNA) or no RNA (-RNA) and protein was followed via absorption at 280 nm. A protein-free sample of the crRNA served as a control of the elution profile (crRNA control). The chromatograms demonstrate that protein is eluting in the fractions 10-18 ml ( Fig. 2A ). The 5'-[γ-32 P]-ATP labeled non-target and target strand of each dsDNA substrate 5.2 or 5.13 were separated on 10% denaturing sequencing gels alongside the 5'-labeled low molecular weight marker (10-100 nt) or a mixture of seven ssDNA fragments (8-66 nt) to specify the fragment length of cleavage hot spots. Lanes marked with C are the loading controls of the dsDNA. 
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